Fobi AI Inc.
FOBIF News Today: Stay Updated with the Latest Fobi AI Inc. News in Real Time
Find FOBIF news now at Meyka AI. Stay informed with the latest Fobi AI Inc. stocks updates, including price news, market analysis, and expert insights.
Jefferies Maintains Buy on CytomX Therapeutics, Inc. (CTMX) $16 PT Mar 2026
CTMX analyst rating: Jefferies maintains Buy and raises PT to $16. Read implications and Meyka AI grade B+
Leerink Maintains Outperform for BTSG BrightSpring Health Services Mar 2026
Leerink maintains Outperform on BTSG. BTSG analyst rating update, market cap, and 1.02% price move explained
NGD.TO New Gold Inc. TSX up 3.31% to C$12.16 March 25 2026: most active stock with C$15.00 upside
NGD.TO stock trades C$12.16 on March 25 2026; Meyka AI flags C$15.00 near-term target for NGD.TO stock
Morgan Stanley Maintains Overweight on Autodesk (ADSK) Mar 2026
Morgan Stanley maintains Overweight; ADSK analyst rating stays unchanged in Mar 2026
Jefferies Maintains Buy on InterDigital, Inc. (IDCC) March 2026
Jefferies maintained Buy on InterDigital; read the IDCC analyst rating, implications, and Meyka AI grade A
3803.T Image Information (JPX) -17.12% intraday 26 Mar 2026: watch JPY 603.00
Intraday update on 3803.T stock: trading JPY 610.00, down 17.12% on JPX with heavy volume; support near JPY 603.00
Raymond James Maintains Strong Buy on Electrovaya Inc (ELVA) March 2026
Raymond James keeps Strong Buy for ELVA. Read the ELVA analyst rating summary, implications, and Meyka grade B+.
3,000,000-volume spike moves BSSP stock 25 Mar 2026 PNK: watch liquidity risk
BSSP stock sees a 3,000,000 volume spike on 25 Mar 2026; assess liquidity, valuation, and model forecasts
Nomura Downgrades Harrow Health (HROW) to Neutral on March 18, 2026
Nomura downgrades Harrow Health to Neutral March 18, 2026. Meyka AI coverage of HROW analyst rating and investor implications.